We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLDP
3501
Ballard Power Systems
BLDP
$805M
$355K ﹤0.01%
72,632
+4,096
+6% +$18.6K
GFI icon
3502
Gold Fields
GFI
$29B
$355K ﹤0.01%
+72,270
New +$393K
SCHE icon
3503
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$355K ﹤0.01%
14,121
-29,824
-68% -$759K
SOXX icon
3504
iShares Semiconductor ETF
SOXX
$41.7B
$355K ﹤0.01%
5,037
-109,107
-96% -$7.53M
IR icon
3505
PUT
Ingersoll Rand
IR
$32.6B
$354K ﹤0.01%
+12,500
New +$386K
SRE.PRB
3506
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
$353K ﹤0.01%
3,000
RVNC
3507
DELISTED
Revance Therapeutics, Inc.
RVNC
$352K ﹤0.01%
27,045
-1,962
-7% -$24K
PEI
3508
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$352K ﹤0.01%
4,102
-5,527
-57% -$468K
AKRX
3509
DELISTED
Akorn Inc
AKRX
$351K ﹤0.01%
92,249
+32,023
+53% +$114K
VYGR icon
3510
Voyager Therapeutics
VYGR
$183M
$350K ﹤0.01%
20,315
+2,354
+13% +$49.4K
AVD icon
3511
American Vanguard Corp
AVD
$68.4M
$349K ﹤0.01%
22,253
+2,312
+12% +$34K
BVH
3512
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$348K ﹤0.01%
14,911
+668
+5% +$14.8K
FFWM
3513
DELISTED
First Foundation Inc
FFWM
$347K ﹤0.01%
22,715
+3,206
+16% +$46.1K
FBMS
3514
DELISTED
The First Bancshares, Inc.
FBMS
$347K ﹤0.01%
10,767
+1,460
+16% +$46.4K
HY icon
3515
Hyster-Yale Materials Handling
HY
$599M
$346K ﹤0.01%
6,315
+1,056
+20% +$58.7K
MNOV icon
3516
MediciNova
MNOV
$65.5M
$346K ﹤0.01%
43,405
+31,537
+266% +$281K
SNN icon
3517
Smith & Nephew
SNN
$13.3B
$346K ﹤0.01%
+7,196
New +$331K
TDW icon
3518
Tidewater
TDW
$3.73B
$346K ﹤0.01%
22,909
+2,753
+14% +$51.9K
SUN icon
3519
Sunoco
SUN
$14.4B
$344K ﹤0.01%
10,947
-2,042
-16% -$65.1K
GTES icon
3520
Gates Industrial Corporation Ltd.
GTES
$7.08B
$343K ﹤0.01%
34,007
+10,338
+44% +$101K
TITN icon
3521
Titan Machinery
TITN
$396M
$343K ﹤0.01%
23,945
-15,783
-40% -$281K
KE
3522
Kimball Electronics
KE
$595M
$341K ﹤0.01%
23,557
+1,135
+5% +$16.8K
KURA icon
3523
Kura Oncology
KURA
$800M
$341K ﹤0.01%
22,453
+3,371
+18% +$60K
AAWW
3524
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$340K ﹤0.01%
13,478
+2,874
+27% +$93.8K
UAE icon
3525
iShares MSCI UAE ETF
UAE
$308M
$339K ﹤0.01%
+25,000
New +$348K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.